Items where Author is "Knoflach, Frédéric"

Article

Costa, Veronica and Aigner, Stefan and Vukcevic, Mirko and Sauter, Evelyn and Behr, Katharina and Ebeling, Martin and Dunkley, Tom and Friedlein, Arno and Zoffmann, Sannah and Meyer, Claas A. and Knoflach, Frédéric and Lugert, Sebastian and Patsch, Christoph and Fjeldskaar, Fatiha and Chicha-Gaudimier, Laurie and Kiialainen, Anna and Piraino, Paolo and Bedoucha, Marc and Graf, Martin and Jessberger, Sebastian and Ghosh, Anirvan and Bischofberger, Josef and Jagasia, Ravi. (2016) mTORC1 Inhibition Corrects Neurodevelopmental and Synaptic Alterations in a Human Stem Cell Model of Tuberous Sclerosis. Cell Reports, 15 (1). pp. 86-95.

Woltering, Thomas J. and Wichmann, Jürgen and Goetschi, Erwin and Knoflach, Frédéric and Ballard, Theresa M. and Huwyler, Jörg and Gatti, Silvia. (2010) Synthesis and characterization of 1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives : Part 4. In vivo active potent and selective non-competitive metabotropic glutamate receptor 2/3 antagonists. Bioorganic & medicinal chemistry letters, Vol. 20, H. 23. pp. 6969-6974.

Vieira, Eric and Huwyler, Jörg and Jolidon, Synèse and Knoflach, Frédéric and Mutel, Vincent and Wichmann, Jürgen. (2009) Fluorinated 9H-xanthene-9-carboxylic acid oxazol-2-yl-amides as potent, orally available mGlu1 receptor enhancers. Bioorganic and Medicinal Chemistry Letters, 19 (6). pp. 1666-1669.

Woltering, Thomas J. and Wichmann, Jürgen and Goetschi, Erwin and Adam, Geo and Kew, James N. C. and Knoflach, Frédéric and Ballard, Theresa M. and Huwyler, Jörg and Mutel, Vincent and Gatti, Silvia. (2008) Synthesis and characterization of 1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: Part 3. New potent non-competitive metabotropic glutamate receptor 2/3 antagonists. Bioorganic and Medicinal Chemistry Letters, 18 (8). pp. 2725-2729.